A Case of Hyperimmunoglobulinemia D Syndrome Successfully Treated with Canakinumab
Hyperimmunoglobulinemia D syndrome is a rare autosomal recessive autoinflammatory disorder caused by mutations in the mevalonate kinase gene (MVK). In a proportion of patients, however, no MVK mutations are detected. Although various standard anti-inflammatory drugs have been tried, until now there...
Saved in:
| Main Authors: | Elena Tsitsami, Charis Papadopoulou, Matthaios Speletas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Case Reports in Rheumatology |
| Online Access: | http://dx.doi.org/10.1155/2013/795027 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neonatal Hepatitis as First Manifestation of Hyperimmunoglobulinemia D Syndrome
by: Marie-Louise von Linstow, et al.
Published: (2014-01-01) -
PERIODIC FEVER SYNDROME (MEVALONATE KINASE DEFICIENCY, HYPERIMMUNOGLOBULINEMIA D SYNDROME) IN CHILDREN
by: Yu. S. Patrusheva, et al.
Published: (2012-03-01) -
Hyperimmunoglobulinemia D Syndrome Masquerading as Familial Mediterranean Fever, Hidradenitis Suppurativa, and Crohn’s Disease: A Case Report
by: Mohamed Juraij, et al.
Published: (2025-04-01) -
Treating TRAPS Syndrome with a Previously Undescribed TNF α Gene Receptor Mutation Successfully with Canakinumab
by: T. V. Sleptsova, et al.
Published: (2016-11-01) -
EXPERIENCE OF THE SUCCESSFUL CANAKINUMAB TREATMENT OF A PATIENT WITH UNDIFFERENTIATED AUTOINFLAMMATORY SYNDROME
by: Tatyana V. Sleptsova, et al.
Published: (2016-11-01)